Fierce New Product Planning 2024

8:30am EDT

Chair Opening Remarks Commonwealth Ballroom

8:45am EDT

PANEL: State of the Industry: Navigating Market Dynamics and Regulatory Changes in Biotech and Pharma Commonwealth Ballroom

9:30am EDT

Innovating to Maximize Multi-Indication Potential

10:00am EDT

Interactive Ice Breaker

11:00am EDT

How to Execute a Modern Launch in a Brave New World: Success 2.0

11:30am EDT

PANEL: Best Practices for Effective Drug Launch Planning

12:15pm EDT

Translating Research to Revenue: Forecasting for Clinical Development Planning and Go-to-Market Strategy

1:45pm EDT

PANEL: Advanced Forecasting - Organizing the Forecasting Process, Future Impact of IRA and AI

2:30pm EDT

Leveraging Generative AI to Expedite Market Landscaping and Commercial Forecasting

3:30pm EDT

PANEL: Navigating Market Access and Pricing Strategies in the Post-IRA Era

4:15pm EDT

Rethinking Asset Development: The Power of Commercial Insights

4:45pm EDT

PANEL: Successful Collaboration Strategies Across R&D, Clinical, and Commercial Teams

9:00am EDT

Day Two Kickoff & Chairperson’s Remarks

9:15am EDT

Strategic Early Positioning for Successful Drug Development

9:45am EDT

From Pipeline Prioritization to Commercialization Strategy: How IRA is Transforming New Product Planning

10:15am EDT

PANEL: Mastering the Art of Target Product Profiles in Drug Development

11:30am EDT

Research-Backed Winners: See What The Top 3 Value-Added Programs in Oncology Are According to the Customer

12:00pm EDT

Maximizing Financial Efficiency and Optionality Through a First-in-Class Product Launch

1:30pm EDT

Revitalizing the Traditional NPP Model

2:00pm EDT

Launching Products, Regardless of the Unmet Patient Need, Face Similar Challenges

2:30pm EDT

PANEL: Is There Such Thing as Too Early: Integrating NPP with Early-Stage R&D

3:15pm EDT

Closing Remarks